Published in BMJ on December 20, 2003
Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med (2005) 10.28
A surrealistic mega-analysis of redisorganization theories. J R Soc Med (2005) 2.38
Comparator bias: why comparisons must address genuine uncertainties. J R Soc Med (2013) 0.99
The nature and influence of pharmaceutical industry involvement in asthma trials. Can Respir J (2012) 0.83
Bad medicine. Elife (2012) 0.75
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev (2012) 10.32
GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Going from evidence to recommendations. BMJ (2008) 7.30
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20
Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2009) 7.07
What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol (2010) 5.78
Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ (2009) 5.68
Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev (2009) 5.57
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10
SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst (2009) 3.93
Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ (2003) 3.92
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65
GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol (2010) 3.60
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58
GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54
SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.45
GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44
SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.34
GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30
Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet (2008) 3.28
GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02
A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci (2013) 3.00
Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst (2006) 2.93
Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91
GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83
Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLoS Med (2006) 2.67
Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ (2002) 2.58
Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57
Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res (2005) 2.50
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Summary-of-findings tables in Cochrane reviews improved understanding and rapid retrieval of key information. J Clin Epidemiol (2010) 2.34
Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care (2006) 2.27
Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci (2013) 2.25
Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst (2006) 2.24
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]. Tidsskr Nor Laegeforen (2002) 2.22
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.20
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.19
SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst (2009) 2.15
Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst (2006) 2.15
Evidence-informed health policy 1 - synthesis of findings from a multi-method study of organizations that support the use of research evidence. Implement Sci (2008) 2.15
User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews. J Clin Epidemiol (2010) 2.12
SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst (2009) 2.05
SUPPORT tools for evidence-informed policymaking in health 6: Using research evidence to address how an option will be implemented. Health Res Policy Syst (2009) 2.02
SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst (2009) 2.00
SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst (2009) 1.99
Incorporating considerations of resources use into grading recommendations. BMJ (2008) 1.94
Evidence summaries tailored to health policy-makers in low- and middle-income countries. Bull World Health Organ (2010) 1.94
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90
Improving the use of research evidence in guideline development: 5. Group processes. Health Res Policy Syst (2006) 1.87
Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev (2008) 1.86
GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol (2012) 1.86
SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review. Health Res Policy Syst (2009) 1.86
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85
SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking. Health Res Policy Syst (2009) 1.84
Medical messages in the media--barriers and solutions to improving medical journalism. Health Expect (2003) 1.84
The origins, evolution, and future of The Cochrane Database of Systematic Reviews. Int J Technol Assess Health Care (2009) 1.84
Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev (2011) 1.82
SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem. Health Res Policy Syst (2009) 1.82
Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev (2011) 1.81
SUPPORT tools for evidence-informed policymaking in health 18: Planning monitoring and evaluation of policies. Health Res Policy Syst (2009) 1.81
Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80
Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst (2006) 1.80
GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol (2012) 1.75
What should clinicians do when faced with conflicting recommendations? BMJ (2008) 1.62
Process evaluation of a cluster randomized trial of tailored interventions to implement guidelines in primary care--why is it so hard to change practice? Fam Pract (2003) 1.61
Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res Policy Syst (2006) 1.57
Blind faith? The effects of promoting active sick leave for back pain patients: a cluster-randomized controlled trial. Spine (Phila Pa 1976) (2002) 1.55
Summaries of findings, descriptions of interventions, and information about adverse effects would make reviews more informative. J Clin Epidemiol (2006) 1.44
[Evaluation of reimbursement applications for new drugs]. Tidsskr Nor Laegeforen (2002) 1.44
Identifying barriers and tailoring interventions to improve the management of urinary tract infections and sore throat: a pragmatic study using qualitative methods. BMC Health Serv Res (2003) 1.43
Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice. PLoS Med (2006) 1.43
Translating research into policy: lessons learned from eclampsia treatment and malaria control in three southern African countries. Health Res Policy Syst (2009) 1.41
Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]. BMC Health Serv Res (2003) 1.32
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol (2012) 1.30
The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial. PLoS Med (2009) 1.29
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Policy Syst (2006) 1.27
Portals to Wonderland: health portals lead to confusing information about the effects of health care. BMC Med Inform Decis Mak (2005) 1.23
The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis. BMC Health Serv Res (2003) 1.23
Framing of health information messages. Cochrane Database Syst Rev (2011) 1.23
NorthStar, a support tool for the design and evaluation of quality improvement interventions in healthcare. Implement Sci (2007) 1.20
Evidence-informed health policy 3 - interviews with the directors of organizations that support the use of research evidence. Implement Sci (2008) 1.16
Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change. BMC Health Serv Res (2004) 1.14
Policymakers' and other stakeholders' perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey. Health Res Policy Syst (2013) 1.10
The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial. PLoS Med (2009) 1.09
Symbols were superior to numbers for presenting strength of recommendations to health care consumers: a randomized trial. J Clin Epidemiol (2007) 1.09
Active sick leave for patients with back pain: all the players onside, but still no action. Spine (Phila Pa 1976) (2002) 1.08
GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med (2008) 1.08
A randomized controlled trial of two strategies to implement active sick leave for patients with low back pain. Spine (Phila Pa 1976) (2002) 1.07
Evidence-informed health policy 4 - case descriptions of organizations that support the use of research evidence. Implement Sci (2008) 1.07
The relation between methods and recommendations in clinical practice guidelines for hypertension and hyperlipidemia. J Fam Pract (2002) 1.06